@article {4998,
	title = {The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.},
	journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
	year = {2015},
	month = {2015 Nov 30},
	abstract = {  The effectiveness of interferon-free direct-acting antivirals (DAA) in treating chronic hepatitis C virus (HCV) is limited by low screening and treatment rates, particularly among people who inject drugs (PWIDs).},
	issn = {1537-6591},
	doi = {10.1093/cid/civ894},
	author = {Durham, David P and Skrip, Laura A and Bruce, Robert Douglas and Vilarinho, Silvia and Elbasha, Elamin H and Galvani, Alison P and Townsend, Jeffrey P}
}
